Possible Direct Influence of Complement 3 in Decreasing Insulin Sensitvity in a Cohort of Overweight and Obese Subjects

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 13, Iss. 4, 2013-12 ,pp. : 301-305

Bentham Science Publishers

Access to resources Recommend Favorite

Low 25 Hydroxyvitamin D Levels are Independently Associated with Autoimmune Thyroiditis in a Cohort of Apparently Healthy Overweight and Obese Subjects

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 18, Iss. 6, 2018-11 ,pp. : 646-652

Bentham Science Publishers

Access to resources Recommend Favorite

Cost of Pharmacological Care of the Elderly: Implications for Healthcare Resources

By O'Neill C.  

Drugs & Aging, Vol. 20, Iss. 4, 2003-01 ,pp. : 253-261

Adis International

Access to resources Recommend Favorite

Oxyntomodulin reduces bodyweight and food intake, and alters levels of adipose hormones in overweight and obese subjects

By  

Inpharma, Vol. 1, Iss. 1503, 2005-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

A Glycemic Threshold of 90 mg/dl Promotes Early Signs of Atherosclerosis in Apparetly Healthy Overweight/Obese Subjects

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 16, Iss. 4, 2017-02 ,pp. : 288-295

Bentham Science Publishers

Access to resources Recommend Favorite